Your email has been successfully added to our mailing list.

×
0.0600522193211489 0.0600522193211489 0.0600522193211489 0.0600522193211489 0 0 0 0.0143603133159269
Stock impact report

Bristol-Myers Squibb applications for new use of O+Y accepted in U.S. and Europe [Seeking Alpha]

ONO PHARM CO UNSP/ADR (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
Company Research Source: Seeking Alpha
The FDA and EMA (European Medicines Agency) haveaccepted for reviewBMYThe FDA's action date is August 6.The company's partner in Japan, Ono Pharmaceutical Co., filed a marketing application there about two weeks ago. Show less Read more
Impact Snapshot
Event Time:
OPHLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for OPHLY alerts
Opt-in for
OPHLY alerts

from News Quantified
Opt-in for
OPHLY alerts

from News Quantified